Loading clinical trials...
Loading clinical trials...
This is a Phase 2, randomized, double-blind, placebo-controlled study of TAT4 Gel for the reduction of moderate to severe nasolabial folds.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Topokine Therapeutics, Inc.
NCT07069920 · Nasolabial Folds
NCT07412392 · Nasolabial Folds, Wrinkles
NCT06657365 · Facial Wrinkles, Anti-Aging, and more
NCT07109635 · Wrinkles Such as Nasolabial Folds
NCT03611491 · Correction of Nasolabial Folds
Topokine Research Site
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions